BrainsWay Ltd. (NASDAQ:BWAY) Q3 2021 Earnings Conference Call November 17, 2021 8:30 AM ET Company Participants Bob Yedid - LifeSci Advisors, IR Christopher von Jako - President and CEO Scott Areglado - Chief Financial Officer Conference Call Participants Steven Lichtman - Oppenheimer Destiny Hance - Ladenburg Thalmann Jayson Bedford - Raymond James Boobalan Pachaiyappan - H.C. Wainwright Operator Greetings and welcome to the BrainsWay Third Quarter 2021 Earnings Conference Call. At this time, all participa ...

Elevating Mental Health Treatments November 2021 Nasdaq/TASE: BWAY Disclaimer Safe Harbor and Non-GAAP Financial Measures This presentation does not constitute an offer or invitation to sell or issue, or any solicitation of an offer to subscribe for or acquire any of the Company's securities or to participate in any investment in the Company. No representation or warranty is made to the accuracy or completeness of this presentation. You must make your own investigation and assessment of the matters containe ...

Exhibit 99.1 BRAINSWAY LTD. 19 Hartum Street, Bynet Building, 3rd Floor Har HaHotzvim, Jerusalem 9777518 Israel NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To Be Held on December 22, 2021 The Annual General Meeting of Shareholders of BrainsWay Ltd. (the "Company"), will be held at the offices of the Company, 19 Hartum Street, Bynet Building, 3rd Fl, Har HaHotzvim, Jerusalem, Israel on December 22, 2021 at 3:00 p.m. Israel time, or at any adjournments thereof (the "Annual Meeting"), for the following pu ...

Elevating Mental Health Treatments Christopher von Jako, PhD September 2021 Nasdaq/TASE: BWAY Disclaimer Safe Harbor and Non-GAAP Financial Measures This presentation does not constitute an offer or invitation to sell or issue, or any solicitation of an offer to subscribe for or acquire any of the Company's securities or to participate in any investment in the Company. No representation or warranty is made to the accuracy or completeness of this presentation. You must make your own investigation and assessm ...

BrainsWay Ltd. (NASDAQ:BWAY) Q2 2021 Earnings Conference Call August 11, 2021 8:30 AM ET Company Participants Brian Ritchie - LifeSci Advisors, IR Christopher von Jako - President and CEO Scott Areglado - Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James Steven Lichtman - Oppenheimer Jeffrey Cohen - Ladenburg Thalmann Jason Wittes - Northland Ram Selvaraju - H.C. Wainwright Operator Greetings. Welcome to the BrainsWay Second Quarter 2021 Earnings Conference Call. At this ti ...

Boldly Advancing Neuroscience August 2021 Nasdaq/TASE: BWAY Disclaimer Safe Harbor and Non-GAAP Financial Measures This presentation does not constitute an offer or invitation to sell or issue, or any solicitation of an offer to subscribe for or acquire any of the Company's securities or to participate in any investment in the Company. No representation or warranty is made to the accuracy or completeness of this presentation. You must make your own investigation and assessment of the matters contained herei ...

BrainsWay Ltd. (NASDAQ:BWAY) Q1 2021 Earnings Conference Call May 20, 2021 8:30 AM ET Company Participants Bob Yedid - LifeSci Advisors, LLC Chris von Jako - President & Chief Executive Officer Scott Areglado - Chief Financial Officer Conference Call Participants Steven Lichtman - Oppenheimer Jeffrey Cohen - Ladenburg Thalmann Kyle Mikson - Cantor Fitzgerald Jason Wittes - Northland Capital Markets Operator Greetings, and welcome to the BrainsWay First Quarter 2021 Earnings Conference Call. At this time, al ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR For the transition period from _____ to ______ ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) ...

BrainsWay Ltd. (NASDAQ:BWAY) Q4 2020 Earnings Conference Call March 25, 2021 8:30 AM ET Company Participants Chase Oswald – LifeSci Advisors Christopher von Jako – President and Chief Executive Officer Hadar Levy – Senior Vice President and General Manager-North America and Interim Chief Financial Officer Conference Call Participants Jayson Bedford – Raymond James Kyle Mixon – Cantor Fitzgerald Jeffrey Cohen – Ladenburg Thalmann Steven Lichtman – Oppenheimer Operator Greetings, and welcome to the BrainsWay ...

Brainsway Ltd. (NASDAQ:BWAY) Q3 2020 Earnings Conference Call November 18, 2020 8:30 AM ET Company Participants Bob Yedid - LifeSci Advisors, Investor Relations Chris von Jako - President & Chief Executive Officer Judy Huber - Chief Financial Officer Conference Call Participants Steven Lichtman - Oppenheimer Jayson Bedford - Raymond James Jeffrey Cohen - Labenberg Kyle Mixon - Cantor Fitzgerald Operator Greetings, and welcome to the Brainsway Third Quarter 2020 Earnings Conference Call. At this time, all pa ...